Great to see @NVIDIAHealth BioNeMo Inference Runtime in public beta. We explored its capabilities in POC testing alongside #AuraIDE.
GPU optimization can make structure prediction faster and more efficient.
Faster inference โ faster iteration โ faster science. ๐
๐ Say hello to faster structure prediction
NVIDIA BioNeMo Inference Runtime is in public beta. This open, PyTorch-native library speeds up biomolecular inference on NVIDIA GPUs.
Optimize models including Boltz-2, OpenFold2, and Protenix v2 with specialized kernels and, where supported, CUDA Graphs - then scale with Ray-powered GPU replicas.
๐ Huge thanks to our collaborators at @apheris_AI, @AurekaBio, @Biomap_IMI, @boltz_bio, @dataiku, @UWproteindesign, @Latent_Labs, MoleculeMind, @nebiusai, @openmsf, @open_fold, @proximabio, @SandboxAQ, @Terray_Tx, and @Xaira_Thera for partnering with us on this work.
๐ https://t.co/JodmVs2s1t
Prompt. Reason. Design your next antibody.
OpenDDE-Harness connects LLM reasoning with structural feedback to design, evaluate, and refine antibodies.
Try the early preview:๐
https://t.co/Rd4iRynXcj
Thank you @Nasdaq for the shout-out on Aurekaโs $100M Series B! With nearly $200M raised to date, weโre excited to keep pushing the frontier of AI-driven therapeutic discovery.
#AIforBiology#TechBio
Aureka has raised $100M in Series B financing๏ผ
With nearly $200M raised to date, weโre entering our next chapter in building AI-native infrastructure for therapeutic discovery and development.
Thank you to our investors, partners, and team.
More: https://t.co/4K5bMopLQ7
Excited to announce our CEO, Dr. Weian Zhao, will keynote at the 15th Annual Biomedical Forum, sharing how Aureka is reshaping therapeutic discovery through digitalization. Join us for this innovative journey! #Biotech#DigitalTherapeutics
With input from experts in the industry, @BTInnovator selects the best & brightest #biotech startups that are developing solutions to advance research & improve human health. We are absolutely thrilled to share #Aureka has been selected to the inaugural #BioToolsInnovator cohort!
Just wrapped up an inspiring week at #PEGS BOSTON2023, where we presented our High Throughput Bispecific Antibody Discovery Pipeline. Grateful for the insightful exchanges. Missed it? Check Dr. Zhao's talk here: [https://t.co/iIj49Grcuq] #PEGSBoston#Biotech#BsAb"
๐ง Landing Page Live - More to Come! ๐ง
Excited to share our live landing page at [https://t.co/1lurUnrZ0p]! Other pages are under constructionโfull website experience coming soon.
Follow our Twitter for updates & launch. Thanks for the support! ๐#LandingPage#Aurekabio
Thrilled to be part of the 2023 @BTInnovator Road Tour's final pitch event today! It was inspiring to see innovative biotools tech and connect with industry leaders. Kudos to all of us! ๐
Are you struggling with inefficiencies in your BsAB discovery process? Our solution doesn't just speed up development, but also uncovers generalizable design principles. Apply for a free trial at https://t.co/Jr6NxvWBPE #AI#pharmaceuticals#drugdiscovery#bispecific#antibodies
Attending #PEGS Boston (May 15-19)? Join our talk on "High Throughput Bispecific Antibody Discovery" (May 17, 10AM) in the "Advancing Bispecific Antibodies and Combination Therapy to Clinic for Oncology" track. Visit booth No.6!#oncology#immunology#drugdiscovery#proteinscience